US 9974802
Composition of novel carbohydrate drug for treatment of human diseases
granted A61KA61K31/70A61K31/715
Quick answer
US patent 9974802 (Composition of novel carbohydrate drug for treatment of human diseases) held by GALECTIN THERAPEUTICS, INC. expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- GALECTIN THERAPEUTICS, INC.
- Grant date
- Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/70, A61K31/715, A61K31/738, A61K45/06